Article

Understanding Pulse Pressure, Biomarkers, and Dementia

ADNI researchers find link to disease progression


 

References

Elevated pulse pressure is associated with neurodegenerative changes prior to the onset of dementia, a retrospective cohort study of 877 adults without dementia in the Alzheimer’s Disease Neuroimaging Initiative found.

Subjects aged 55 to 91 years old underwent a baseline health assessment that included blood pressure measurements and lumbar puncture for biomarkers phosphorylated tau (P-tau) and b-amyloid 1-42. Researchers tracked subjects for progression to dementia for 6 to 96 months and found:

• Regardless of age, all P-tau–positive subjects had elevated pulse pressure.

• Subjects 80 years and older with both elevated P-tau and reduced b-amyloid 1-42 had an even greater increase in pulse pressure, compared to peers without or with only 1 biomarker.

• Higher baseline pulse pressure was associated with a more rapid progression to dementia.

Citation: Nation DA, Edmonds EC, Bangen KJ, et al; Alzheimer’s Disease Neuroimaging Initiative Investigators. Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol. 2015. doi: 10.1001/jamaneurol.2014.4477.

Recommended Reading

Cognitive Decline in Alzheimer’s Varies by Age
MDedge Neurology
Cognitive Decline, APOE ε4 Status, and Sex
MDedge Neurology
Does Amyloid Accumulation Cause Midlife Cognitive Decline?
MDedge Neurology
Investigational cancer drug now tested for treating Alzheimer’s
MDedge Neurology
Olfactory deficits may signal cognitive decline
MDedge Neurology
Gene newly linked to mild Alzheimer’s pathology
MDedge Neurology
Cerebrospinal fluid marker predicts brain atrophy
MDedge Neurology
HS3ST2 enzyme expression increased in Alzheimer’s brains
MDedge Neurology
Behavioral symptoms in dementia need a global touch
MDedge Neurology
Metabolic monitoring suboptimal for dementia patients taking antipsychotics
MDedge Neurology